公司资料
TherapeuticsMD 股价、新闻与催化剂
- 股票代码:
- TXMD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.01 USD (-2.90%)
收盘价
最后更新: 2026年8月17日
23.6M USD
市值
股价为何变动
As of Aug 17, 2026, TXMD closed down 2.90% at $2.01. No new same-company headline was identified in the current news window.
公司概览
Pharmaceutical Royalty Company
TherapeuticsMD owns rights to royalties and license revenue from women's health pharmaceutical products rather than operating a broad internal commercial organization.
Royalty Portfolio Model
Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without directly funding commercialization. The business focuses on collecting contractual economics and preserving remaining intellectual property rights.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。